Cyclin D1 gene amplification and p16 gene deletion in patients with esophageal carcinosarcoma

Diagnostic Molecular Pathology

Volumn 7, Issue 5, 1998, Pages 253-259

  Suzuki, Hiroaki ^a,b   Fujioka, Yasunori ^c,d   Nagashima, Kazuo ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b KUSHIRO ROSAI HOSPITAL   (Japan)

^c HOKKAIDO UNIVERSITY HOSPITAL   (Japan)

^d KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Amplification; Cyclin D1; Differential polymerase chain reaction; Fluorescence in situ hybridization; Homozygous deletion; P16

Indexed keywords

CYCLIN D1; DNA; PROTEIN P16;

ADULT; AGED; ARTICLE; CARCINOSARCOMA; CASE REPORT; CONTROLLED STUDY; ESOPHAGUS CARCINOMA; FLUORESCENCE IN SITU HYBRIDIZATION; FLUORESCENCE MICROSCOPY; GENE AMPLIFICATION; GENE DELETION; HUMAN; HUMAN TISSUE; MALE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SOUTHERN BLOTTING;

EID: 0032420801     PISSN: 10529551     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019606-199810000-00004     Document Type: Article

References (24)

1. DeCaprio JA, Ludlow JW, Lynch D, et al. The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element. Cell 1989;58:1085-95.
2. Gramlich TL, Fritsch CR, Maurer D, Eberle M, Gansler TS. Differential polymerase chain reaction assay of cyclin D1 gene amplification in esophageal carcinoma. Diagn Mol Pathol 1994;3: 255-9.
3. Grana X, Reddy P. Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs). Oncogene 1995;11:211-9.
4. Hunter T, Pines J. Cyclins and cancer II: cyclin D and CDK inhibitors come of age. Cell 1994;79:573-82.
5. Igaki H, Sasaki H, Kishi T, et al. Highly frequent homozygous deletion of the p16 gene in esophageal cancer cell lines. Biochem Biophys Res Commun 1994;203:1090-5.
6. Kallioniemi OP, Kallioniemi A, Kurisu W, et al. ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization. Proc Natl Acad Sci USA 1992;89:5321-5.
7. Kamb A, Gruis NA, Weaver-Feldhause J, et al. A cell cycle regulator potentially involved in genesis of many tumor types. Science 1994;264:436-40.
8. Koh J, Enders GH, Dynlacht BD, et al. Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition. Nature 1995; 375:506-10.
9. Kwaitkowski D, Mehl R, Yin HL. Genomic organization and biosynthesis of secreted and cytoplasmic forms of gelsolin. J Cell Biol 1988;106:375-84.
10. Lewin KJ, Appleman HD. Tumors of the esophagus and stomach. Washington, DC: Armed Forces Institute of Pathology, 1995:83-8.
11. Lukas J, Parry D, Aagaard L, et al. Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16. Nature 1995;375:503-6.
12. McGrath JP, Capon DJ, Smith DH, et al. Structure and organization of the human Ki-ras proto-oncogene and a related processed pseudogene. Nature 1983;304:501-6.
13. ink4 requires functional retinoblastoma protein. Proc Natl Acad Sci USA 1995;92:6289-93.
14. Merlo A, Herman JG, Mao L, et al. 5′CpH island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nature Med 1995;1: 686-92.
15. Micale MA, Visscher DW, Gulino SE, et al. Chromosomal aneuploidy in proliferative breast disease. Hum Pathol 1994;25: 29-35.
16. Mori T, Miura K, Aoki T, Nishihara T, Mori S, Nakamura Y. Frequent somatic mutation of the MTS1/CDK4I (multiple tumor suppressor/cyclin-dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma. Cancer Res 1994;54:3396-7.
17. Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K, Carson DA. Deletion of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 1994;368:753-6.
18. INK4A genes in astrocytomas. Diagn Mol Pathol 1997;6:115-22.
19. Rosai J. Ackerman's surgical pathology. 8th ed. St. Louis: Mosby, 1996:603-5.
20. Ross JS, Sheehan CE, Hayner-Buchan AM, et al. Prognostic significance of HER-2/neu gene amplification status by fluorescence in situ hybridization of prostate carcinoma. Cancer 1997;79:2162-70.
21. Serrano M, Hannon GJ, Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 1993;366:704-7.
22. Sheyn I, Noffsinger ARE, Heffelfinger S, Davis B, Miller MA, Fenoglio-Preiser CM. Amplification and expression of the cyclin D1 gene in anal and esophageal squamous cell carcinomas. Hum Pathol 1997;28:270-6.
23. Suzuki H, Moriya J, Nakahata A, Fujioka Y, Inoue K, Nagashima K. Cyclin D1 gene amplification in esophageal carcinosarcoma shown by differential polymerase chain reaction. Hum Pathol 1998;29:662-7.
24. Ueki K, Ono Y, Henson JW, Efird JT, von Deimling A, Louis DN. CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated. Cancer Res 1996;56:150-3.